Lido Advisors, LLC Dexcom Inc Transaction History

Lido Advisors, LLC

$20.3 Billion
Q3 2024

A detailed history of Lido Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Lido Advisors, LLC holds 17,694 shares of DXCM stock, worth $1.42 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,694

Previous 17,529 0.94%

Holding current value

$1.42 Million

Previous $1.99 Million 40.36%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $10,560 - $19,149	165 Added 0.94%	17,694 $1.19 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $4.82 Million - $6.14 Million	-43,690 Reduced 71.37%	17,529 $1.99 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $382,751 - $469,475	3,351 Added 5.79%	61,219 $8.49 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $118,519 - $194,931	1,570 Added 2.79%	57,868 $7.18 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $4.54 Million - $7.28 Million	52,748 Added 1485.86%	56,298 $5.25 Million
Q2 2023 Aug 09, 2023	BUY	$112.47 - $130.98 $59,384 - $69,157	528 Added 17.47%	3,550 $456,000
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $9,256 - $10,939	-89 Reduced 2.86%	3,022 $351,000
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $17,930 - $25,883	-211 Reduced 6.35%	3,111 $352,000
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $112,692 - $139,009	-1,476 Reduced 30.76%	3,322 $267,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $228,378 - $446,377	3,359 Added 233.43%	4,798 $357,000
Q1 2022 May 17, 2022	BUY	$94.08 - $130.2 $12,512 - $17,316	133 Added 10.18%	1,439 $736,000
Q4 2021 Feb 15, 2022	BUY	$129.87 - $162.82 $6,363 - $7,978	49 Added 3.9%	1,306 $701,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $16,860 - $22,622	158 Added 14.38%	1,257 $687,000
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $1,457 - $1,942	18 Added 1.67%	1,099 $469,000
Q1 2021 May 13, 2021	SELL	$84.79 - $104.74 $7,376 - $9,112	-87 Reduced 7.45%	1,081 $389,000
Q4 2020 Feb 08, 2021	BUY	$78.0 - $104.5 $2,262 - $3,030	29 Added 2.55%	1,168 $432,000
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $33,715 - $39,871	-353 Reduced 23.66%	1,139 $470,000
Q2 2020 Aug 12, 2020	SELL	$62.68 - $105.34 $564 - $948	-9 Reduced 0.6%	1,492 $605,000
Q1 2020 May 13, 2020	SELL	$47.79 - $75.63 $477 - $756	-10 Reduced 0.66%	1,501 $404,000
Q4 2019 Feb 07, 2020	SELL	$36.62 - $57.29 $32,994 - $51,618	-901 Reduced 37.35%	1,511 $331,000
Q1 2019 May 10, 2019	SELL	$28.07 - $38.18 $1,852 - $2,519	-66 Reduced 2.66%	2,412 $287,000
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $66,881 - $92,602	2,478 New	2,478 $296,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.

Account

Lido Advisors, LLC Dexcom Inc Transaction History